Viewing Study NCT04633902


Ignite Creation Date: 2025-12-25 @ 3:47 AM
Ignite Modification Date: 2025-12-26 @ 2:34 AM
Study NCT ID: NCT04633902
Status: UNKNOWN
Last Update Posted: 2022-12-06
First Post: 2020-11-12
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase II Study of Olaparib and Pembrolizumab in Advanced Melanoma With Homologous Recombination (HR) Mutation
Sponsor: California Pacific Medical Center Research Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module